Alembic Pharma achieves USFDA final approval for Oseltamivir Oral Suspension, a Tamiflu equivalent, enhancing its market presence.
SENSEX 77,100.47
+ 109.25
NIFTY 24,056.00
+ 34.35
CRUDEOIL 6,809.00
Alembic Pharmaceuticals has secured USFDA approval for its generic oseltamivir phosphate oral suspension, a key treatment for…
Alembic Pharmaceuticals receives USFDA approval for generic Dapsone gel, a topical acne treatment equivalent to Aczone.
Alembic Pharmaceuticals receives USFDA approval for generic levothyroxine sodium tablets, a key treatment for hypothyroidism.
Alembic Pharma receives USFDA tentative approval for 45 mg generic Binimetinib tablets, targeting cancer treatment market.
Glenmark launches generic vancomycin hydrochloride injection in the US, enhancing its injectable portfolio and treatment options.
Granules India achieves First-to-File status for generic Lumryz tablets in the US, enhancing its position in complex generics.
